Search

everythinglearnresearchcommunity

for

Search:↓

Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Older patients sticking to their prostate medication saw lasting health benefits.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Upadacitinib may effectively treat resistant lichen planopilaris.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

New compounds may help treat heart disease by activating specific potassium channels.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

The FDA approved using Cialis with Proscar for better treatment options.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.